US stocks wavered on Thursday as traders parsed various corporate earnings against a backdrop of aggressive interest-rate hikes by global central banks. The US yield curve remained inverted as recession fears persisted. The S&P 500 ended the session little changed after fluctuating throughout the day. The Nasdaq 100 closed up higher for the second straight …
Rs 6,250-cr IPO was approved: PharmEasy’s parent company withdraws DRHP
Fearing volatility in stock markets, API Holdings, the parent company of healthtech unicorn PharmEasy, has withdrawn its draft red herring prospectus (DRHP) that it had filed with the Securities and Exchange Board of India (Sebi), the company informed its shareholders in a note. The pre-IPO draft papers, which were filed late last year, are being …